Published • loading... • Updated
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreichs Ataxia
Summary by ADKhabar
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreichs Ataxia
June 26, 2026 16:05 ET | Source: Larimar Therapeutics Webcast on Monday, June 29, 2026, at 7:45 am ET BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor […] The post Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program fo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
